Insights from 2023 ESGO Annual Meeting
A

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comparing Weekly Dose-Dense Chemo + Bev to 3-Weekly Chemo + Bev in 1L HR Stage 3-4 Epithelial Ovarian Cancer - Primary PFS Analysis"

By Insights from 2023 ESGO Annual Meeting FEATURING Andrew Clamp
By Insights from 2023 ESGO Annual Meeting FEATURING Andrew Clamp
274 views
October 11, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Recommended

14:45

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

1.0K views
11:15

2024 Updates in Ovarian Cancer

Total Health

T. Tillmanns

436 views
13:15

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

425 views
15:45

Defining Platinum Resistance in Ovarian Cancer

Michael Birrer

534 views
27:14

Management of Recurrent Ovarian Clear Cell Carcinoma

David Tan

440 views
10:46

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

214 views
13:21

The Role of Surgery in Stage IV Ovarian Cancer

Insights from 2024 ESMO Gynaecological Cancers Congress

C. Fotopoulou

328 views
19:30

Precision Oncology in the Management of Ovarian Cancer

Miami Cancer Institute Precision Oncology Symposium

D. Dizon

270 views
23:53

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

276 views
06:50

Year in Review: Ovarian Cancer

Fengting Yan

441 views
25:10

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

5.1K views
12:56

UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…

UChicago Medicine Annual Practice Updates in Hematology and Oncology

H. Cun

160 views
11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau
18:16

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer"

Insights from 2024 ESGO Annual Meeting

J. Kurtz

360 views
06:23

Recent Highlights in Ovarian Cancer

Total Health

B. Slomovitz

534 views
13:01

Treatment Options for Platinum-Sensitive Recurrent Ovarian Cancer

Richard Penson

161 views
05:09

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective Gluco…

Insights from 2024 SGO Annual Meeting

N. Colombo

260 views
22:52

New

Addressing the Critical Gaps in Relapsed Ovarian Cancer Management

Michael Birrer

98 views
17:06

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Ovarian Cancer Midwest Focus, University of Minnesota

S. Lheureux

302 views
03:55

SGO 2024 Insights: "COMB1NE Study - Characteristics and Real-World O…

Insights from 2024 SGO Annual Meeting

P. Thaker

182 views
AUTOPLAY